Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis
Public ClinicalTrials.gov record NCT00955825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase III Study of the Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Administered as Allergen-based Tablets Once Daily to Adult Patients Suffering From Grass Pollen Rhinoconjunctivitis
Study identification
- NCT ID
- NCT00955825
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Stallergenes Greer
- Industry
- Enrollment
- 473 participants
Conditions and interventions
Conditions
Interventions
- 300 IR Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2008
- Primary completion
- Jul 31, 2009
- Completion
- Jul 31, 2009
- Last update posted
- May 18, 2016
2008 – 2009
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sneeze, wheeze, and Itch Associates, LLC | Normal | Illinois | 61761 | — |
| University of Kentucky Medical Center | Lexington | Kentucky | 40508 | — |
| Allergy & Asthma Specialists, PSC | Owensboro | Kentucky | 42301 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| Respiratory Medical Research Institute of Michigan PLC | Ypsilanti | Michigan | 48197 | — |
| Clinical Research of the Ozarks, Inc. | Columbia | Missouri | 65203 | — |
| Midwest Clinical Research LLC | St Louis | Missouri | 63141 | — |
| Clinical Research of the Ozarks, Inc | Warrensburg | Missouri | 64093 | — |
| Montana Allergy & Asthma Specialists | Billings | Montana | 59101 | — |
| Montana Medical Research | Missoula | Montana | 59808 | — |
| Creighton University - Allergy & Asthma | Omaha | Nebraska | 68131 | — |
| Bernstein Clinical Research Center, LLC | Cincinnati | Ohio | 45231 | — |
| Allergy and Asthma Research Group | Eugene | Oregon | 97401 | — |
| Baker Allergy, Asthma, & Dermatology Research Center, LLC | Lake Oswego | Oregon | 97035 | — |
| Clinical Research Institute of Southern Oregon, P.C. | Medford | Oregon | 97504 | — |
| Allergy Associates Research | Portland | Oregon | 97213 | — |
| Allergy & Clinical Immunology Associates | Pittsburgh | Pennsylvania | 15241 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37203 | — |
| North West Asthma Allergy Center | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00955825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00955825 live on ClinicalTrials.gov.